Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR DELIVERY OF AAV

Last updated:

Abstract:

The disclosure provides compositions and methods for the preparation, manufacture, formulation and therapeutic use of adeno-associated virus (AAV) particles for the prevention and/or treatment of diseases.

Status:
Application
Type:

Utility

Filling date:

11 Oct 2019

Issue date:

2 Dec 2021